Answer
Women should not breastfeed throughout Tasigna (nilotinib) treatment and for 2 weeks after the last dose because a risk to newborns or infants cannot be excluded.
Sources for this answer
- Tasigna 50mg, 150mg and 200 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 39Document updated
Sources checked